drugset / Trial / NCT03390036
Study of Cingal for the Relief of Knee Osteoarthritis Compared to Triamcinolone Hexacetonide at 39 Weeks Follow up
RandomizedParallel-groupDouble-blindTreatment
Summary
Extension study to Cingal 16-02 to obtain 39-week safety and efficacy follow-up data
Timeline
- Start
- 2017-12-07
- Primary completion
- 2018-07-30
- Completion
- 2018-07-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hyaluronic Acid | Other / unclassified | 88 mg | Other |
| Comparator | Triamcinolone Hexacetonide | Other / unclassified | 18 mg | Other |
| Comparator | Triamcinolone Hexacetonide | Other / unclassified | 20 mg | Other |